Disclosures for "Comparative Efficacy and Safety of Irreversible (Rasagiline) and Reversible (Safinamide) Monoamine Oxidase Inhibitors as Add-on Therapy for Parkinson’s Disease"
-
Miss Khalid has nothing to disclose.
-
Mr. Shahzad has nothing to disclose.
-
Miss Siddiqui has nothing to disclose.
-
Dr. Zain-ul-Abedin has nothing to disclose.
-
Saad Hulou has nothing to disclose.
-
Dr. Shami has nothing to disclose.
-
Dr. Ijlal Ahmed has nothing to disclose.